CDC42 and melanoma: A melanoma patient-derived xenograft was implanted into the flanks of NSG mice, and when the tumors reached a volume of 150–200 mm3, they were treated with the indicated doses of the CDC42 inhibitor ARN22089, vemurafenib, or vehicle twice daily for 2 weeks by oral gavage (Figure 2A).